Mizuho Securities Sticks to Its Buy Rating for Molina Healthcare (MOH)
In a report released on April 17, Ann Hynes from Mizuho Securities maintained a Buy rating on Molina Healthcare, with a price target of $170.00. The company’s shares closed last Friday at $148.97.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hynes covers the Healthcare sector, focusing on stocks such as Acadia Healthcare, HCA Healthcare, and Molina Healthcare. According to TipRanks, Hynes has an average return of 4.5% and a 53.82% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Molina Healthcare with a $142.77 average price target, a -4.16% downside from current levels. In a report released on April 10, Bernstein also maintained a Buy rating on the stock with a $173.00 price target.
Based on Molina Healthcare’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $11.38 billion and a GAAP net loss of $160 million. In comparison, last year the company earned a revenue of $10.5 billion and had a net profit of $251 million
Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is neutral on the stock. Last month, Ronna Romney, a Director at MOH sold 506.00 shares for a total of $74,341.52.
Read More on MOH:
Disclaimer & DisclosureReport an Issue
- One in seven enrollees in ACA plans failed to make payments this year, WSJ says
- Midday Fly By: Health insurers get ‘positive surprise’ from CMS
- Deutsche sees margin pressure despite ‘positive surprise’ from CMS
- Molina Healthcare price target raised to $152 from $145 at BofA
- Closing Bell Movers: Health insurers rise on higher Medicare rate hike
